Key facts
- The employee, in his 60s, was an executive at Astellas Pharma's Chinese unit and a senior official of the Japanese Chamber of Commerce and Industry in China.
- He was sentenced to three years and six months in July 2025 and did not appeal, according to the source.
- He would serve his entire sentence, including part of the period between detention and the ruling.
